Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuyan Lei

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2026
Trimethyllysine as a potential biomarker for heart failureYuyan Lei, Qing Fang, Qingqi Wu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 3, 2025
Plasma reference interval of Trimethylamine-N-oxide in healthy adults: A multicenter study using Trimethylamine-N-oxide assay kit for analysis and validationQing Fang, Yuyan Lei, Hao Wu, et al.
Renal Failure|November 13, 2025
Gut microbiota-derived TMAO drives the kidney-bone-vascular axis in chronic kidney disease complicationsYuyan Lei, Guiling Xiong, Dongyu Lei, et al.
Clinical Pharmacology in Drug Development|September 23, 2023
Bioequivalence of Blonanserin Tablets Under Fasting and Fed Conditions in Healthy Chinese SubjectsYuyan Lei, Yu Yan, Junli Lu, et al.
Applied Microbiology and Biotechnology|April 22, 2025
The microbiome-derived metabolite trimethylamine N-oxide is associated with chronic kidney disease riskJunyi Jiang, Peng Zhu, Xiaoying Ding, et al.
Communications Biology|April 10, 2025
The gut microbiota metabolite trimethylamine N-oxide promotes cardiac hypertrophy by activating the autophagic degradation of SERCA2aDongyu Lei, Yi Liu, Yuan Liu, et al.
Clinical Pharmacology in Drug Development|November 18, 2025
Bioequivalence Study of Two Olopatadine Hydrochloride Tablets in Chinese Healthy Subjects Under Fasting and Fed ConditionsYuyan Lei, Fang Pei, Qingqi Wu, et al.
Frontiers in Pharmacology|March 6, 2025
Pharmacokinetics and bioequivalence of two formulations of the S-1 (tegafur/gimeracil/oxonate) capsule in Chinese cancer patients under fasting and fed conditions: a multicenter, randomized, open-label, single-dose, double-cycle crossover studyJunli Lu, Yuyan Lei, Yuanyuan Mo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 4, 2026
Trimethylamine N-Oxide Combined with Phenylacetylglutamine as Potential Biomarkers for Diabetic Kidney DiseaseGuiling Xiong, Qing Fang, Hao Wu, et al.
Clinical Pharmacology in Drug Development|June 9, 2025
Comparative Pharmacokinetics and Bioequivalence of Two Sodium Valproate Tablets in Healthy Chinese Subjects Under Fasting and Fed ConditionsYuan Liu, Xueqiong Peng, Mengfei Zhao, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2026
Trimethyllysine as a potential biomarker for heart failureYuyan Lei, Qing Fang, Qingqi Wu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 3, 2025
Plasma reference interval of Trimethylamine-N-oxide in healthy adults: A multicenter study using Trimethylamine-N-oxide assay kit for analysis and validationQing Fang, Yuyan Lei, Hao Wu, et al.
Renal Failure|November 13, 2025
Gut microbiota-derived TMAO drives the kidney-bone-vascular axis in chronic kidney disease complicationsYuyan Lei, Guiling Xiong, Dongyu Lei, et al.
Clinical Pharmacology in Drug Development|September 23, 2023
Bioequivalence of Blonanserin Tablets Under Fasting and Fed Conditions in Healthy Chinese SubjectsYuyan Lei, Yu Yan, Junli Lu, et al.
Applied Microbiology and Biotechnology|April 22, 2025
The microbiome-derived metabolite trimethylamine N-oxide is associated with chronic kidney disease riskJunyi Jiang, Peng Zhu, Xiaoying Ding, et al.
Communications Biology|April 10, 2025
The gut microbiota metabolite trimethylamine N-oxide promotes cardiac hypertrophy by activating the autophagic degradation of SERCA2aDongyu Lei, Yi Liu, Yuan Liu, et al.
Clinical Pharmacology in Drug Development|November 18, 2025
Bioequivalence Study of Two Olopatadine Hydrochloride Tablets in Chinese Healthy Subjects Under Fasting and Fed ConditionsYuyan Lei, Fang Pei, Qingqi Wu, et al.
Frontiers in Pharmacology|March 6, 2025
Pharmacokinetics and bioequivalence of two formulations of the S-1 (tegafur/gimeracil/oxonate) capsule in Chinese cancer patients under fasting and fed conditions: a multicenter, randomized, open-label, single-dose, double-cycle crossover studyJunli Lu, Yuyan Lei, Yuanyuan Mo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 4, 2026
Trimethylamine N-Oxide Combined with Phenylacetylglutamine as Potential Biomarkers for Diabetic Kidney DiseaseGuiling Xiong, Qing Fang, Hao Wu, et al.
Clinical Pharmacology in Drug Development|June 9, 2025
Comparative Pharmacokinetics and Bioequivalence of Two Sodium Valproate Tablets in Healthy Chinese Subjects Under Fasting and Fed ConditionsYuan Liu, Xueqiong Peng, Mengfei Zhao, et al.
Pageof 3